ISAB repositions its Contract Research business and launches “Inhalation Research Services” as new brand name
(Stockholm, 20 August 2020) Inhalation Sciences AB (ISAB) is repositioning its Contract Research business and launching it under a new brand name - Inhalation Research Services (IRS). IRS offers a comprehensive service portfolio that delivers precise and predictive early-stage respiratory research data. IRS has seen a steady increase in demand from its biopharma customers and has grown considerably during the Covid-19 pandemic.ISAB is organizing its operations into three business areas: The first is the sales of its PreciseInhale[® ]system and modules, the second is IRS, providing contract